Cardiol Therapeutics Inc. (CRDL.TO)
CAD 1.96
(0.51%)
CAD 1.96
(0.51%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 158.53 Thousand CAD | 606.97% |
| 2022 | 22.42 Thousand CAD | -69.23% |
| 2021 | 72.87 Thousand CAD | -30.37% |
| 2020 | 104.65 Thousand CAD | -25.4% |
| 2019 | 140.27 Thousand CAD | -47.89% |
| 2018 | 269.21 Thousand CAD | 41.66% |
| 2017 | 190.04 Thousand CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 142.55 Thousand CAD | 0.0% |
| 2024 Q1 | 150.66 Thousand CAD | -100.0% |
| 2023 Q4 | 158.53 Thousand CAD | 4.2% |
| 2023 Q2 | - CAD | -100.0% |
| 2023 Q1 | 9089.00 CAD | -59.47% |
| 2023 FY | 158.53 Thousand CAD | 606.97% |
| 2023 Q3 | 152.14 Thousand CAD | 0.0% |
| 2022 Q2 | 48.19 Thousand CAD | -20.55% |
| 2022 Q4 | 22.42 Thousand CAD | -36.75% |
| 2022 FY | 22.42 Thousand CAD | -69.23% |
| 2022 Q1 | 60.66 Thousand CAD | -16.75% |
| 2022 Q3 | 35.45 Thousand CAD | -26.43% |
| 2021 Q1 | 95.18 Thousand CAD | -9.05% |
| 2021 FY | 72.87 Thousand CAD | -30.37% |
| 2021 Q4 | 72.87 Thousand CAD | -2.27% |
| 2021 Q3 | 74.56 Thousand CAD | -12.54% |
| 2021 Q2 | 85.25 Thousand CAD | -10.43% |
| 2020 Q1 | 131.62 Thousand CAD | -6.17% |
| 2020 FY | 104.65 Thousand CAD | -25.4% |
| 2020 Q4 | 104.65 Thousand CAD | -8.06% |
| 2020 Q3 | 113.82 Thousand CAD | -7.31% |
| 2020 Q2 | 122.79 Thousand CAD | -6.71% |
| 2019 Q4 | 140.27 Thousand CAD | -5.67% |
| 2019 Q2 | 154.45 Thousand CAD | 0.0% |
| 2019 Q1 | - CAD | -100.0% |
| 2019 FY | 140.27 Thousand CAD | -47.89% |
| 2019 Q3 | 148.71 Thousand CAD | -3.72% |
| 2018 Q4 | 269.21 Thousand CAD | -97.86% |
| 2018 Q1 | - CAD | -100.0% |
| 2018 Q2 | 10.05 Million CAD | 0.0% |
| 2018 FY | 269.21 Thousand CAD | 41.66% |
| 2018 Q3 | 12.57 Million CAD | 25.13% |
| 2017 FY | 190.04 Thousand CAD | 0.0% |
| 2017 Q4 | 190.04 Thousand CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aurora Cannabis Inc. | 47.57 Million CAD | 99.667% |
| Avicanna Inc. | 95.36 Thousand CAD | -66.242% |
| Avant Brands Inc. | 1.74 Million CAD | 90.894% |
| Crescita Therapeutics Inc. | 815 Thousand CAD | 80.548% |
| Knight Therapeutics Inc. | 44.01 Million CAD | 99.64% |
| MediPharm Labs Corp. | 69 Thousand CAD | -129.757% |
| OrganiGram Holdings Inc. | 79 Thousand CAD | -100.673% |
| Canopy Growth Corporation | 493.29 Million CAD | 99.968% |
| Willow Biosciences Inc. | 594 Thousand CAD | 73.311% |
| Auxly Cannabis Group Inc. | 81.38 Million CAD | 99.805% |